Close Menu
iM.NewsiM.News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    New Method Could Detect Quantum Superposition of Time

    November 21, 2026

    USDA and FBI Systems Breached Amid US Tech Outages

    November 21, 2026

    Safety fears rise over Black Friday liquid BBL deals

    November 21, 2026
    Facebook X (Twitter) Instagram
    iM.NewsiM.News
    Subscribe
    • Home
    • Lifestyle

      Safety fears rise over Black Friday liquid BBL deals

      November 21, 2026

      Richard Hammond on Divorce, Speeding, and Life After Top Gear

      November 21, 2026

      Northern Ireland Doctors Strike Ends, New Walkout Planned

      November 21, 2026

      Vienna’s Culinary Identity: A Borderless European Legacy

      November 21, 2026

      Stockholm Winter: Traditions, Lights, and Ice Skating

      November 21, 2026
    • Relations

      USDA and FBI Systems Breached Amid US Tech Outages

      November 21, 2026

      Zelensky defends Crimean Bridge strikes as UK minister visits Kyiv

      November 21, 2026

      UK-EU Trade and Youth Deals Signed as Rejoining Talks Loom

      November 21, 2026

      UN AI Weapons Talks Stall, Extend Deadline to 2028

      November 21, 2026

      Zelensky Calls Putin a Killer After Trump’s ‘Friend’ Comment

      November 21, 2026
    • Technology

      Xiaomi 18 Pro Review: Dual Screens and Flagship Cameras

      November 21, 2026

      AI Model Compresses 1GB Wikipedia to 105MB

      November 21, 2026

      ESA Hera Probe Arrives at Asteroids From NASA DART Test

      November 21, 2026

      Anthropic Shares Slide as Tech Sell-Off Deepens

      November 21, 2026

      Indian Startup Sues Apple Over NameDrop Patent

      November 21, 2026
    • Travel & Tourism

      Accor Shareholder Pushes to Oust CEO After Ennismore Deal

      November 21, 2026

      TAP Air Portugal Adds Nonstop Porto Service from Washington Dulles

      November 20, 2026

      Oil Spills Threaten UAE and Oman Beaches Amid Hormuz Conflict

      November 20, 2026

      Aer Lingus to Retrofit A330 Fleet with Premium Economy and New Business Class

      November 20, 2026

      Sabre Targets AI Travel Bookings With New Connector

      November 20, 2026
    • Get in Touch
    iM.NewsiM.News
    Home»Lifestyle»Health»GLP-1 Weight Loss Drugs Linked to Nail Detachment
    Health

    GLP-1 Weight Loss Drugs Linked to Nail Detachment

    im.newsBy im.newsOctober 12, 2026No Comments5 Mins Read11 Views
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Close up of fingernail detachment on a hand
    Photo: Raimond Spekking / Wikimedia Commons, CC BY-SA 4.0
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    Patients using popular GLP-1 medications for weight loss and type 2 diabetes are reporting nail detachment at rates far higher than those who do not take the drugs, according to a new multinational study. The findings, presented at the European Academy of Dermatology and Venereology (EADV) Congress 2026, identify a consistent pattern of nail and scalp changes among users of these widely prescribed treatments.

    Researchers found that 39% of GLP-1 users experienced nail detachment, a condition where the nail separates from the skin underneath it. This rate was more than four times higher than the 9% reported by people who had never taken the medications. Nail discoloration was also considerably more common, affecting 46% of users compared with 17% of nonusers. Overall, two-thirds of GLP-1 users reported at least one nail disorder.

    Study Participants and Methodology

    The research examined 575 people using GLP-1 medications and compared them with 1,329 individuals who had type 2 diabetes or obesity but had never used the drugs. Participants were recruited from France, the United States, Brazil, and Mexico. This controlled study represents the first investigation to systematically look at the possible relationship between GLP-1 medications and nail health, moving beyond the individual anecdotal reports that had previously circulated.

    GLP-1 receptor agonists have become increasingly popular for managing obesity and type 2 diabetes. These medications act on a hormone signaling system that helps regulate blood sugar and appetite, making them effective tools for improving metabolic health and supporting weight loss. However, scientists are still investigating their potential effects on other parts of the body.

    Hair Loss and Scalp Inflammation

    A companion study examining the same participants identified significant differences in hair and scalp health among people taking GLP-1 medications. Half of GLP-1 users reported unusual hair loss, compared with 34% of nonusers. Reduced hair volume or density was also substantially more common, affecting 42% of users versus 19% of the control group.

    Researchers additionally examined hair loss that began after treatment started. This was reported by 26% of GLP-1 users, compared with 12% of nonusers, making it more than twice as common in the medication group. Scalp redness was approximately three times more frequent among GLP-1 users. A particularly interesting finding was that hair loss rarely appeared by itself. Most users who reported shedding also experienced other scalp symptoms, including itching, redness or flaking skin.

    These accompanying symptoms raised the possibility that inflammation could be contributing to the changes, rather than the hair loss being explained entirely by rapid weight reduction. “This suggests that what is happening on the scalp may go beyond the classical shedding seen after rapid weight loss and involve an inflammatory component,” explained study author Dr. Bruno Halioua. “Scalp inflammation was the rule rather than the exception, which clinicians do not currently look for and which may be treatable.”

    Detachment of a fingernail
    Photo: Threecharlie / Wikimedia Commons, CC BY-SA 3.0

    Weight Loss vs. Medication Effects

    One important question was whether the nail problems might simply be related to weight loss, rather than to the medications themselves. Rapid changes in body weight can affect nutrition and other physiological processes, potentially influencing nail and hair health. However, the researchers found that weight loss did not fully account for the differences. Even when they limited their analysis to participants who had lost weight, GLP-1 users continued to report significantly more nail problems than those who had not used the medications.

    The researchers emphasized that their findings do not prove that GLP-1 drugs cause nail disorders. Approximately half of the medication users said they had experienced nail problems even before beginning treatment. When the researchers accounted for existing skin conditions and nutritional deficiencies, some of the differences between the groups became smaller. Nevertheless, nail detachment and discoloration remained approximately two to three times more common among GLP-1 users after these adjustments.

    “Until now, nail changes associated with GLP-1 therapies had essentially been anecdotal,” said study author Dr. Charles Ta eb. “Our findings show a clear association, but they also underline an important point: not everything that happens during GLP-1 treatment is necessarily caused by the treatment itself.”

    Despite the relatively high frequency of reported symptoms, the researchers stressed that the findings should encourage awareness rather than alarm. “These changes are frequent, usually benign, and are not a reason to stop an effective treatment on one’s own initiative,” Dr. Halioua said. “Anyone who notices hair shedding, an itchy or red scalp or nail changes should mention it to their doctor rather than discontinue therapy.”

    There are also important limitations to consider. Both investigations were cross-sectional studies, meaning they examined participants’ experiences without following them over time to establish how symptoms developed. The findings also relied on symptoms reported by participants rather than standardized clinical examinations. As a result, the studies can reveal patterns and associations, but cannot determine whether GLP-1 medications directly caused the reported nail, hair, or scalp problems.

    To investigate these questions more thoroughly, the research team plans to conduct prospective studies that follow patients from the beginning of treatment. These investigations will include standardized skin, hair and nail examinations along with biological monitoring. The goal is to establish when the changes first appear, identify the mechanisms behind them, and determine whether they improve or disappear over time. The research received institutional support from DUCRAY Laboratories (Pierre Fabre Group).

    Source: ScienceDaily

    dermatology EADV GLP-1 hair loss Health nail health weight loss
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleMicrosoft President Calls for AI ‘Kill Switches’ Amid Safety Fears
    Next Article How Cinema Helped a Grieving Young Adult Reconnect
    im.news

    Related Posts

    New Method Could Detect Quantum Superposition of Time

    November 21, 2026

    USDA and FBI Systems Breached Amid US Tech Outages

    November 21, 2026

    Safety fears rise over Black Friday liquid BBL deals

    November 21, 2026
    Leave A Reply Cancel Reply

    Latest Posts

    New Method Could Detect Quantum Superposition of Time

    November 21, 20261 Views

    USDA and FBI Systems Breached Amid US Tech Outages

    November 21, 20263 Views

    Safety fears rise over Black Friday liquid BBL deals

    November 21, 20264 Views

    Xiaomi 18 Pro Review: Dual Screens and Flagship Cameras

    November 21, 20263 Views
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025 News Focus 247 Views

    In a stunning development that has sent shockwaves through political and entertainment circles, Attorney General…

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide the daily life news. You find latest trendy news at our portal, from entertainment to economy or politics.

    We're accepting new partnerships right now.

    Email Us: info@im.news

    Facebook X (Twitter) RSS
    Our Picks

    New Method Could Detect Quantum Superposition of Time

    November 21, 2026

    USDA and FBI Systems Breached Amid US Tech Outages

    November 21, 2026

    Safety fears rise over Black Friday liquid BBL deals

    November 21, 2026
    Most Popular

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025247 Views

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025208 Views

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025165 Views
    © 2026 I'm News. Designed by I'm News.
    • Home
    • Lifestyle
    • Relations
    • Travel & Tourism
    • Technology

    Type above and press Enter to search. Press Esc to cancel.